Literature DB >> 17194173

Emergency department visits caused by adverse drug events: results of a French survey.

Patrice Queneau1, Bernard Bannwarth, Françoise Carpentier, Jean-Michel Guliana, Jacques Bouget, Béatrice Trombert, Xavier Leverve, Frédéric Lapostolle, Stephen W Borron, Frédéric Adnet.   

Abstract

BACKGROUND: Adverse drug events (ADEs) are a substantial cause of hospital admissions. However, little is known about the incidence, preventability and severity of ADEs resulting in emergency department visits. To address this issue, we conducted a prospective survey in emergency departments of French public hospitals.
METHODS: This study was performed over two periods of 1 week each, one in June 1999 and one in December 1999, in emergency departments of five university hospitals and five general hospitals throughout France. All patients aged>or=15 years presenting with medical complaints were included in the study. Trauma patients, those with gynaecological conditions and those with alcohol intoxication or intentional drug poisoning were excluded from the study. Each patient was assessed by two local emergency physicians to determine whether the visit was the result of an ADE. All medical records were subsequently validated by an independent group of medical lecturers in iatrogenic disorders.
RESULTS: Out of a total of 1937 patients consulting, 1562 were taking at least one drug during the previous week and were included for analysis; 328 (21%; 95% CI 19, 23) of these patients consulted an emergency physician because of an ADE. Patients with ADEs were older than those without (mean age 63.5 vs 54.8 years; p<0.0001). Furthermore, ADE patients were more likely to have a higher severity presentation than the non-ADE group (p=0.019). The number of drug exposures was significantly higher in patients with an ADE than in those without (mean number of medications 5.17 vs 3.82; p<0.0001). On multivariate analysis, only age and the number of medications taken were significantly associated with adverse events. In total, 410 drugs were incriminated in the occurrence of 328 ADEs. The most frequently incriminated drug classes were: (i) psychotropic agents (n=84; 20.5%); (ii) diuretics (n=48; 11.7%), anticoagulants (n=38; 9.3%) and other cardiovascular drugs (n=63; 15.4%); and (iii) analgesics, including NSAIDs (n=57; 13.9%). Preventability could be assessed in 280 of the 328 cases. In 106 cases (37.9%), the ADE was judged to be preventable.
CONCLUSION: ADEs leading to emergency department visits are frequent, and many are preventable, confirming that there is a need to develop prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17194173     DOI: 10.2165/00002018-200730010-00008

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  26 in total

Review 1.  Preventable medical injuries in older patients.

Authors:  J M Rothschild; D W Bates; L L Leape
Journal:  Arch Intern Med       Date:  2000-10-09

2.  Establishing health care performance standards in an era of consumerism.

Authors:  K W Kizer
Journal:  JAMA       Date:  2001-09-12       Impact factor: 56.272

3.  Incidence and preventability of adverse drug events in nursing homes.

Authors:  J H Gurwitz; T S Field; J Avorn; D McCormick; S Jain; M Eckler; M Benser; A C Edmondson; D W Bates
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

4.  [Prevention of avoidable iatrogenic disease: when patient safety joins with health care economics].

Authors:  P Queneau; J F Bergmann
Journal:  Therapie       Date:  2001 Mar-Apr       Impact factor: 2.070

5.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

6.  National adverse drug reaction surveillance: 1985.

Authors:  G A Faich; D Knapp; M Dreis; W Turner
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

7.  Adverse drug events in emergency department patients.

Authors:  John W Hafner; Steven M Belknap; Marc D Squillante; Kay A Bucheit
Journal:  Ann Emerg Med       Date:  2002-03       Impact factor: 5.721

8.  Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?

Authors:  P Carbonin; M Pahor; R Bernabei; A Sgadari
Journal:  J Am Geriatr Soc       Date:  1991-11       Impact factor: 5.562

9.  [Iatrogenic disease observed in a hospital setting. II. Analysis of causes and suggestions for novel preventive measures].

Authors:  P Queneau; J M Chabot; H Rajaona; C Boissier; P Grandmottet
Journal:  Bull Acad Natl Med       Date:  1992-05       Impact factor: 0.144

10.  Inappropriate prescribing for elderly Americans in a large outpatient population.

Authors:  Lesley H Curtis; Truls Østbye; Veronica Sendersky; Steve Hutchison; Peter E Dans; Alan Wright; Raymond L Woosley; Kevin A Schulman
Journal:  Arch Intern Med       Date:  2004 Aug 9-23
View more
  22 in total

1.  Drug-related visits to the emergency department in a Spanish university hospital.

Authors:  Isabel Castro; José Ma Guardiola; Laura Tuneu; Ma Luisa Sala; Ma José Faus; Ma Antonia Mangues
Journal:  Int J Clin Pharm       Date:  2013-05-22

2.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.

Authors:  Peter J Zed; Riyad B Abu-Laban; Robert M Balen; Peter S Loewen; Corinne M Hohl; Jeffrey R Brubacher; Kerry Wilbur; Matthew O Wiens; Leslie J Samoy; Katie Lacaria; Roy A Purssell
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

3.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  Preventability of adverse effects of analgesics: analysis of spontaneous reports.

Authors:  Irina Cazacu; Ghada Miremont-Salamé; Cristina Mogosan; Annie Fourrier-Réglat; Felicia Loghin; Françoise Haramburu
Journal:  Eur J Clin Pharmacol       Date:  2015-03-05       Impact factor: 2.953

5.  Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention.

Authors:  Cristina Silva; Célia Ramalho; Isabel Luz; Joaquim Monteiro; Paula Fresco
Journal:  Int J Clin Pharm       Date:  2015-01-31

6.  Preventability analysis of adverse drug reactions detected in two internal medicine departments in Romania.

Authors:  Andreea Farcas; Camelia Bucsa; Aura Sinpetrean; Daniel Leucuta; Cristina Mogosan; Dan Dumitrascu; Andrei Cadariu Achimas; Marius Bojita
Journal:  Intern Emerg Med       Date:  2012-08-21       Impact factor: 3.397

7.  Negative clinical outcomes of medication resulting in emergency department visits.

Authors:  María Isabel Baena; Paloma C Fajardo; Antonio Pintor-Mármol; M José Faus; Rosario Marín; Antonio Zarzuelo; José Martínez-Olmos; Fernando Martínez-Martínez
Journal:  Eur J Clin Pharmacol       Date:  2013-10-03       Impact factor: 2.953

8.  Regional surveillance of emergency-department visits for outpatient adverse drug events.

Authors:  A Capuano; A Irpino; M Gallo; L Ferrante; M L Illiano; B Rinaldi; A Filippelli; F Rossi
Journal:  Eur J Clin Pharmacol       Date:  2009-03-18       Impact factor: 2.953

9.  Potentially inappropriate prescribing in a population of frail elderly people.

Authors:  Isabelle Récoché; Cécile Lebaudy; Charlène Cool; Sandrine Sourdet; Antoine Piau; Maryse Lapeyre-Mestre; Bruno Vellas; Philippe Cestac
Journal:  Int J Clin Pharm       Date:  2016-12-10

10.  Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006).

Authors:  Pilar Carrasco-Garrido; López Ana de Andrés; Valentín Hernández Barrera; Gil Angel de Miguel; Rodrigo Jiménez-García
Journal:  BMC Health Serv Res       Date:  2010-10-13       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.